Dr. Yvonne Reinders
Ausgewählte Publikationen
Clinical and Experimental Medicine, Bd. 26, Nr. 1, 2026
Lang A, Pang TY, Piel S, Oehler D, Zweck E, Shahrjerdi K, Okkasian M, Georgy J, Reinders Y, Duplessis A, Tank J, Jordan J, Pfeiler S, Sickmann A,…
Oxygen-dependent modulation of the human complement system during acute normobaric hypoxia: a translational plasma proteomics study
https://doi.org/10.1007/s10238-026-02084-9
Journal of Proteome Research, Bd. 2025, 2025, S. 484-490
Lange E, Schallert K, Schwerdt J, Ghosh S, Hentschel A, Reinders Y, Heyer R.
The Omics Molecule Extractor: A Web Application for the Selection of Potential Biomarker Panels
https://doi.org/10.1021/acs.jproteome.5c00176
Proteomics. Clinical applications, Bd. 20, Nr. 1, 2025
Thilmany S, Thomas A, Reinders Y, Shakeri F, Vogel M, Sickmann A, Scholl C, Thevis M.
Hormonal Contraceptives and Depression: A Proteomic Analysis Using Neuronal Models
https://doi.org/10.1002/prca.70017
Antibodies, Bd. 14, Nr. 1, 2025
Döring S, Weller MG, Reinders Y, Konthur Z, Jaeger C.
Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review
Pharmacological Research, Bd. 211, 2024, S. 107558
Brand T, Baumgarten BT, Denzinger S, Reinders Y, Kleindl M, Schanbacher C, Funk F, Gedik N, Jabbasseh M, Kleinbongard P, Dudek J, Szendroedi J,…
From Ca2+ dysregulation to heart failure: β-adrenoceptor activation by RKIP postpones molecular damages and subsequent cardiac dysfunction in mice carrying mutant PLNR9C by correction of aberrant Ca2+-handling
https://doi.org/10.1016/j.phrs.2024.107558
Biomedicines, Bd. 12, Nr. 10, 2024
Lang A, Oehler D, Benkhoff M, Reinders Y, Maike B, Shahrjedi K, Kaldirim M, Sickmann A, Dannenberg L, Polzin A, Pfeiler S, Kelm M, Grandoch M, Jung…
Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction
https://doi.org/10.3390/biomedicines12102368
GIT Labor-Fachzeitschrift, Bd. 2024, Nr. 03, 2024, S. 20-23
Reinders Y, Hentschel A, Sickmann A.
Massenspektrometrie im Therapeutischen Drug Monitoring
Clinical Proteomics, Bd. 21, Nr. 1, 2024, S. 12
Hentschel A, Piontek G, Dahlmann R, Findeisen P, Sakson R, Carbow P, Renné T, Reinders Y, Sickmann A.
Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data
https://doi.org/10.1186/s12014-024-09464-x
Molecular Oncology, Bd. 18, Nr. 2, 2023, S. 431-452
Schulz D, Feulner L, Santos Rubenich D, Heimer S, Rohrmüller S, Reinders Y, Falchetti M, Wetzel M, Braganhol E, Lummertz da Rocha E, Schäfer N,…
Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy
https://doi.org/10.1002/1878-0261.13567
Biomedicines, Bd. 11, Nr. 10, 2023
Wang C, Stöckl S, Pattappa G, Schulz D, Hofmann K, Ilic J, Reinders Y, Bauer RJ, Sickmann A, Grässel S.
Extracellular Vesicles Derived from Osteogenic-Differentiated Human Bone Marrow-Derived Mesenchymal Cells Rescue Osteogenic Ability of Bone Marrow-Derived Mesenchymal Cells Impaired by Hypoxia
https://doi.org/10.3390/biomedicines11102804